NPP
CELG

New Potomac Partners’s Celgene Corp CELG Stock Holding History

New Potomac Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,575
Closed -$1.25M – 140
2019
Q3 		$1.25M Sell
12,575
-110
-0.9% -$10.5K 1.25% 37
2019
Q2 		$1.17M Sell
12,685
-20
-0.2% -$1.9K 1.19% 39
2019
Q1 		$1.2M Sell
12,705
-95
-0.7% -$8.31K 1.21% 39
2018
Q4 		$820K Sell
12,800
-7,785
-38% -$575K 0.88% 42
2018
Q3 		$1.84M Buy
20,585
+11,545
+128% +$1.02M 1.71% 29
2018
Q2 		$718K Sell
9,040
-330
-4% -$27.4K 0.69% 45
2018
Q1 		$836K Sell
9,370
-3,065
-25% -$294K 0.82% 44
2017
Q4 		$1.3M Buy
+12,435
New +$1.4M 1.24% 37

Other funds holding CELG

HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

New Potomac Partners's CELG Position: Q4 2019 in Review

New Potomac Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 12,575 shares — an estimated $1.25M sold.

New Potomac Partners first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $1.84M in Q3 2018. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • New Potomac Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • New Potomac Partners sold 12,575 Celgene Corp shares in Q4 2019, an estimated $1.25M.
  • New Potomac Partners first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • New Potomac Partners's Celgene Corp position peaked at $1.84M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on New Potomac Partners's 13F filing for Q4 2019, filed 23 Jan 2020.